- For Patients
- Introduction to the Marshall Protocol
-
Length of the MP - Immunopathology
- Managing Immunopathology
- Food and Drink
- Light Restriction
- Suitability of the Marshall Protocol
- Starting the Marshall Protocol
- Working with a Physician
- Phase One Guidelines
- Phase Two/Three Guidelines
- Palliative vs. Curative Treatments
- Patient Interviews on Bacteriality
- Non-MP Treatments
- Glossary
- For Physicians
- Publications and Presentations
- Science Behind Marshall Protocol
- Science Behind Immunopathology
- Science Behind Olmesartan (Benicar)
- Safety of Olmesartan (Benicar)
- Safety of MP Antibiotics
- Phase One Guidelines
- Phase Two/Three Guidelines
- Suitability of the Marshall Protocol
- Physicians' Concerns About the MP
- Notice for Emergency Medical Personnel
- For Researchers
- Publications and Presentations
- Science Behind Marshall Pathogenesis
- Science Behind Vitamin D
- Molecular Activity of Vitamin D and the VDR in Chronic Disease
- Th1 Spectrum Disorder – how chronic inflammatory diseases are related
- Transmission of Bacteria and Onset of Chronic Disease
- Pea Soup, Successive Infection, and Variability in Disease
- Evolutionary Perspective on Chronic Disease
- Incidence and Prevalence of Chronic Disease
- Evidence that Chronic Disease Is Caused by Pathogens
- Diseases
- About ARF
- Related Sites
Warning: array_diff() [function.array-diff]: Argument #1 is not an array in /home/mpkborg5/public_html/lib/plugins/tag/helper.php on line 280
Warning: array_diff() [function.array-diff]: Argument #1 is not an array in /home/mpkborg5/public_html/lib/plugins/tag/helper.php on line 280
Table of Contents
Diseases
According to the Marshall PathogenesisA description for how chronic inflammatory diseases originate and develop., chronic inflammatory disease is caused by a microbiotaThe bacterial community which causes chronic diseases - one which almost certainly includes multiple species and bacterial forms. of bacteria, including L-form bacteriaDifficult-to-culture bacteria that lack a cell wall and are not detectable by traditional culturing processes. Sometimes referred to as cell wall deficient bacteria., biofilmA structured community of microorganisms encapsulated within a self-developed protective matrix and living together. bacteria, and intracellular bacterial forms. These bacterial forms are collectively known as the Th1 pathogens, and they collectively cause the Th1 diseases. Although the exact species and forms of bacteria, as well as the location and extent of the infection, vary between one patient suffering from chronic disease and the next, the disease process is common: bacterial pathogens persist and reproduce by disabling the innate immune responseThe body's first line of defense against intracellular and other pathogens. According to the Marshall Pathogenesis the innate immune system becomes disabled as patients develop chronic disease..
As counterintuitive as the theory of a Th1 Spectrum Disorder may seem to some medical specialists, it has been the experience of Autoimmunity Research FoundationNon-profit foundation dedicated to exploring a pathogenesis and therapy for chronic disease. that nearly all MP patients with inflammatory disease eventually respond with immunopathologyA temporary increase in disease symptoms experienced by Marshall Protocol patients that results from the release of cytokines and endotoxins as disease-causing bacteria are killed.–the predictable rise and fall of symptoms, which is taken to be a sign of progress.
Some diseases are represented by more patients trying the therapy than others. As more patients join the MP cohort, the Autoimmunity Research Foundation will gather more data about the efficacy of the treatment with respect to individual diseases. In the meantime, the MP may be considered a potentially worthwhile treatment option for any of the diseases listed below.
Dozens of different patients have shared their stories of recovery on Bacteriality.com.
Difficulty in diagnosing specific diseases
Th1 Spectrum DisorderThe overlap of different disease symptoms in different patients with similar diagnoses - caused by the fact that any one bacterial species can contribute to numerous disease states. refers to the group of chronic inflammatory diseases, which are caused by the Th1 pathogens, a microbiota of bacteria which include L-form, biofilm, and intracellular bacterial forms. Although the exact species and forms of bacteria, as well as the location and extent of the infection, vary between one patient suffering from chronic disease and the next, the disease process is common: bacterial pathogens persist and reproduce by disabling the innate immune response.
Although patients who become infected with the Th1 pathogens are given a variety of diagnoses, there are often no clear cut distinctions between one disease and the next. Rather, symptoms frequently overlap creating a spectrum of illness in which diseases are more connected to one another than mutually exclusive disease states.
The evidence that chronic disease is ultimately a spectrum disorder caused by a common infectious cause includes:
- comorbidity of inflammatory diseases overlap observed between patients suffering distinctly defined diseases
- the infrequency with which patients suffer from just a single disease or condition
- failure of diagnostic compartmentalization: the frequent difficulty doctors have in clearly and definitively diagnosing a patient
List of diseases
home/diseases.txt · Last modified: 02.04.2010 by paulalbert
© 2010, Autoimmunity Research Foundation. All Rights Reserved.
